• Publications
  • Influence
Abstract 986: High content analysis of 2D and 3D oncology models for target and phenotypic drug discovery
Charles River (CR) has developed many disease-relevant cellular models to screen small molecules and genetic modifiers for target and phenotypic based drug discovery. Our expertise and portfolio inExpand